-
EdU Flow Cytometry Assay Kits (Cy5) Protocol Guide
2026-08-22
EdU Flow Cytometry Assay Kits (Cy5) provide a flow cytometry cell proliferation assay for measuring DNA synthesis during the S-phase through EdU incorporation and Cy5 click labeling. The kit is suited to proliferation, genotoxicity, and pharmacodynamic experiments, but EdU signal should not be treated as standalone evidence of completed cell division or used without pilot validation in untested cell types and multiplex panels.
-
Cy3-UTP for Fluorescent RNA Labeling
2026-08-21
Cy3-UTP is a Cy3-modified uridine triphosphate for generating fluorescent RNA by in vitro transcription. Its reported water solubility, 95% purity, and light-protected storage specification support controlled workflows for fluorescence imaging of RNA, RNA-protein interaction studies, and RNA detection assays.
-
Nile Red for Quantitative Lipid Droplet Imaging
2026-08-20
Nile Red enables dual-channel visualization of lipid droplets, but reliable lipid biology requires more than fluorescence intensity alone. This guide presents an orthogonal, measurement-focused workflow for intracellular lipid droplet staining, lipid distribution imaging, and lipid storage dynamics analysis.
-
Direct Mouse Genotyping Kit: Practical PCR Workflow
2026-08-20
The Direct Mouse Genotyping Kit supports rapid PCR amplification from mouse tissue lysates without conventional DNA purification, making it useful for routine colony screening and high-throughput genotyping. It is intended for PCR-based assays rather than applications requiring highly purified genomic DNA or downstream analyses such as sequencing.
-
NFIA Coordinates Bone Remodeling and Mass Accrual
2026-08-19
A recent Genes & Diseases study identifies nuclear factor I/A (NFIA) as a context-dependent regulator of bone homeostasis in mesenchymal stem and progenitor cells. By suppressing RANKL-driven osteoclastogenesis while also restraining osteoblast differentiation through SFRP1 and Wnt/β-catenin signaling, NFIA produces a dual but unbalanced effect in which control of bone resorption predominates.
-
4-Ethylphenyl Sulfate Research Workflows
2026-08-19
Build more informative renal biomarker, surface adsorption, and gut microbiota-brain interaction assays with 4-ethylphenyl sulfate. This workflow emphasizes matrix-matched controls, toxin-aware biomaterial testing, and practical troubleshooting for reproducible results.
-
TNF-alpha Recombinant Murine Protein: A Signaling Lens
2026-08-18
Explore how TNF-alpha recombinant murine protein can function as a mechanistic reference for apoptosis, inflammation, and transcriptional-stress studies. This guide connects tumor necrosis factor alpha biology with the RNA Pol II degradation-dependent apoptotic response and translates that distinction into better assay design.
-
Genetically Engineered Mouse Models of Mesothelioma
2026-08-18
Kadariya and colleagues present a protocol-centered framework for modeling mesothelioma using genetically engineered mice carrying Bap1 alterations and, where appropriate, additional tumor-suppressor defects or asbestos exposure. The work shows how germline, conditional, and autochthonous models can connect mesothelioma genetics with inflammation, tumor development, and preclinical therapeutic testing in immunocompetent animals.
-
Amiloride (MK-870) for Ion-Transport Assays
2026-08-17
Amiloride (MK-870) is a practical perturbation tool for separating ENaC- and uPAR-associated effects from antigen uptake, trafficking, and presentation. This workflow connects sodium channel research with the ER-targeted immunoliposome strategy reported in a recent vaccine study while clearly distinguishing established findings from assay hypotheses.
-
Recombinant Mouse M-CSF: Applied Workflows
2026-08-17
Build more reproducible mouse macrophage, osteoclast, cancer, and fibrosis assays with a tag-free M-CSF workflow. This guide connects controlled macrophage differentiation to metabolic and inflammatory readouts inspired by the IGF2BP1–THBS1–TLR4 pulmonary fibrosis axis.
-
B-Cell Ether Lipids Shape Germinal Centers
2026-08-16
The reference study shows that B-cell-intrinsic PexRAP, encoded by Dhrs7b, supports ether phospholipid production, B-cell survival, germinal center development, and effective antibody maturation. Its combination of inducible genetic models, imaging mass spectrometry, immunization, and mechanistic cell analysis provides a framework for connecting lipid metabolism with humoral immunity.
-
Tyrothricin in Reliable Viability Assays
2026-08-15
Learn how Tyrothricin (SKU BA1054) can be integrated into viability, cytotoxicity, and infection-model workflows without conflating antimicrobial effects with mammalian cell injury. This scenario-based guide covers controls, membrane-disruption studies, storage, redox-related interpretation, and practical vendor selection.
-
Tamoxifen in PINK1–Iron Cancer Models
2026-08-14
Tamoxifen is more than a selective estrogen receptor modulator in conditional cancer models: it can determine when and how CreER-mediated gene knockout is interpreted. This article connects tamoxifen experimental design with PINK1-dependent mitochondrial iron biology while separating genetic effects from drug-induced confounding.
-
Cy3-UTP and the Spatial Logic of RNA Processing
2026-08-14
A mechanistic and translational perspective on how Cy3-UTP can help researchers test RNA localization, nuclear speckle organization, and co-transcriptional processing hypotheses inspired by new findings on Alu repeat-containing RNAs.
-
Relative vs Fractional Viability in Cancer Drug Studies
2026-08-13
Hannah R. Schwartz’s 2022 dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central finding is that drug-induced growth inhibition and cell death usually occur together, but in different proportions and with distinct timing, providing a stronger framework for interpreting in vitro pharmacology.